Biodesix, Inc. BDSX Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s other commercial liabilities?
- Biodesix, Inc. (BDSX) reported other commercial liabilities of $8.23M in Q1 2026.
- How has Biodesix, Inc.'s other commercial liabilities changed year-over-year?
- Biodesix, Inc.'s other commercial liabilities increased by 11.2% year-over-year, from $7.4M to $8.23M.
- What is the long-term trend for Biodesix, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Biodesix, Inc.'s other commercial liabilities has grown at a 7.2% compound annual growth rate (CAGR), from $7.79M to $11.03M.